Please try another search
Celsion Corporation (NASDAQ:CLSN) popped out of a falling wedge or pennant two days ago, took an inside day on low volume, and then on Monday, it popped 60 cents, or 19.6%, to 3.66, with a multi-week and session high of 3.79, on 4.9 million shares traded and another 7 cents to 3.73 in after-hours. That was a good breakout day. Now, I’m looking for a move to 4 1/2 and 5 1/2.
Inovio Pharmaceuticals (NASDAQ:INO) also may have popped on Monday and took out the declining topsline and prior highs. It gained 1.13, or 8.7%, to 14.15, just pennies off the session high at 14.19, on 20.4 million shares traded. I’m looking for a test of 15 1/4. If it gets through 15 3/4-16 1/2 the sky is the limit.
Novavax (NASDAQ:NVAX) popped out of a month-long coil on Monday and jumped 5.50, or 12%, to 51.07, with a session high of 51.53, on 8.6 million shares traded, and another 36 cents to 51.43 in after-hours. That wasn’t a big move, but we do want to see resistance taken out at 54. If it does that, 60 and 70 are the targets.
Origin Agritech (NASDAQ:SEED) exploded 1.98, or 31%, to 8.36, with a midafternoon session high of 8.49, on 543,791 shares traded on Monday. You can see that this might be an interesting play. Next targets are 11 and 14.
Soliton (NASDAQ:SOLY) on Monday announced its new device for removing cellulite and popped 74 cents, or 5.4%, to 14.55, with a session high of 15.50, on 1.3 million shares traded, and another 40 cents in after-hours to 14.95. That’s the biggest volume in almost eight months. There’s a quadruple top up here around 15.60. Keep an eye on it, because if it gets through here, 19 and 22 are targets.
VBI Vaccines (NASDAQ:VBIV), which Andre picked out on Monday, looks good. It wedged, popped, pulled back, and then exploded 43 cents, or 20%, to 2.60, with a session high of 2.80, on 29.4 million shares traded. That’s a lot of volume for this stock. If it gets through the 2.95 area, we’re looking at 4-4 1/4 next as target.
Stocks on the long side included Cloudera, Inc. (NYSE:CLDR), Celldex (NASDAQ:CLDX) Therapeutics, Inc. (CLDX), Celsion Corporation (CLSN), Digital Ally, Inc. (NASDAQ:DGLY), DraftKings Inc. (NASDAQ:DKNG), Dynavax (NASDAQ:DVAX) Technologies Corporation (DVAX), GenMark Diagnostics, Inc. (NASDAQ:GNMK), GSX Techedu Inc. (NYSE:GSX), Inovio Pharmaceuticals, Inc. (INO), MediciNova, Inc. (MNOV), Momenta Pharmaceuticals, Inc. (MNTA), Moderna, Inc. (NASDAQ:MRNA), Cloudflare, Inc. (NET), NIO Inc. (NIO), NantKwest, Inc. (NASDAQ:NK), Nikola Corporation (NKLA), Novavax, Inc. (NVAX), Purple Innovation, Inc. (NASDAQ:PRPL), Peloton Interactive, Inc. (NASDAQ:PTON), Origin Agritech Limited (SEED), Soliton, Inc. (SOLY), Teladoc Health, Inc. (NYSE:TDOC), ZOOM Technologies, Inc. (ZOOM), VBI Vaccines Inc. (VBIV), Veritone, Inc. (NASDAQ:VERI), Wrap Technologies, Inc. (NASDAQ:WRTC), and Zynex, Inc. (NASDAQ:ZYXI).
After a brief hiatus, we’re back with a fresh set of Pro Picks - and PulteGroup Inc (NYSE:PHM) is a rock-solid highlight among four top stocks that have not only earned top...
The US stock market is attempting to bounce back on Friday after the heavy sell-off on Wednesday and Thursday. The Nasdaq 100 index was close to key levels where it reversed gains...
S&P Emini Pre-Open Market Analysis The S&P 500 Futures formed a strong bear breakout with follow-through on the daily chart, which broke below the August low and the 4,400 big...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.